Literature DB >> 24941423

Respiratory syncytial virus increases the virulence of Streptococcus pneumoniae by binding to penicillin binding protein 1a. A new paradigm in respiratory infection.

Claire M Smith1, Sara Sandrini, Sumit Datta, Primrose Freestone, Sulman Shafeeq, Priya Radhakrishnan, Gwyneth Williams, Sarah M Glenn, Oscar P Kuipers, Robert A Hirst, Andrew J Easton, Peter W Andrew, Christopher O'Callaghan.   

Abstract

RATIONALE: Respiratory syncytial virus (RSV) and Streptococcus pneumoniae are major respiratory pathogens. Coinfection with RSV and S. pneumoniae is associated with severe and often fatal pneumonia but the molecular basis for this remains unclear.
OBJECTIVES: To determine if interaction between RSV and pneumococci enhances pneumococcal virulence.
METHODS: We used confocal microscopy and Western blot to identify the receptors involved in direct binding of RSV and pneumococci, the effects of which were studied in both in vivo and in vitro models of infection. Human ciliated respiratory epithelial cell cultures were infected with RSV for 72 hours and then challenged with pneumococci. Pneumococci were collected after 2 hours exposure and changes in gene expression determined using quantitative real-time polymerase chain reaction.
MEASUREMENTS AND MAIN RESULTS: Following incubation with RSV or purified G protein, pneumococci demonstrated a significant increase in the inflammatory response and bacterial adherence to human ciliated epithelial cultures and markedly increased virulence in a pneumonia model in mice. This was associated with extensive changes in the pneumococcal transcriptome and significant up-regulation in the expression of key pneumococcal virulence genes, including the gene for the pneumococcal toxin, pneumolysin. We show that mechanistically this is caused by RSV G glycoprotein binding penicillin binding protein 1a.
CONCLUSIONS: The direct interaction between a respiratory virus protein and the pneumococcus resulting in increased bacterial virulence and worsening disease outcome is a new paradigm in respiratory infection.

Entities:  

Keywords:  G protein; cilia; pneumococcus; respiratory syncytial virus; virulence

Mesh:

Substances:

Year:  2014        PMID: 24941423      PMCID: PMC4226051          DOI: 10.1164/rccm.201311-2110OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  39 in total

1.  Analysis of ciliary beat pattern and beat frequency using digital high speed imaging: comparison with the photomultiplier and photodiode methods.

Authors:  M A Chilvers; C O'Callaghan
Journal:  Thorax       Date:  2000-04       Impact factor: 9.139

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

3.  MicroPreP: a cDNA microarray data pre-processing framework.

Authors:  Sacha A F T van Hijum; Jorge García de la Nava; Oswaldo Trelles; Jan Kok; Oscar P Kuipers
Journal:  Appl Bioinformatics       Date:  2003

4.  Host cellular immune response to pneumococcal lung infection in mice.

Authors:  A Kadioglu; N A Gingles; K Grattan; A Kerr; T J Mitchell; P W Andrew
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

5.  The effects of coronavirus on human nasal ciliated respiratory epithelium.

Authors:  M A Chilvers; M McKean; A Rutman; B S Myint; M Silverman; C O'Callaghan
Journal:  Eur Respir J       Date:  2001-12       Impact factor: 16.671

6.  Bronchiolitis-associated hospitalizations among US children, 1980-1996.

Authors:  D K Shay; R C Holman; R D Newman; L L Liu; J W Stout; L J Anderson
Journal:  JAMA       Date:  1999-10-20       Impact factor: 56.272

7.  Exhaled and sputum nitric oxide in bronchiectasis: correlation with clinical parameters.

Authors:  Kenneth W Tsang; Raymond Leung; Peter Chin-Wan Fung; Shelley L Chan; George L Tipoe; Gaik C Ooi; Wah K Lam
Journal:  Chest       Date:  2002-01       Impact factor: 9.410

8.  Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology.

Authors:  Liqun Zhang; Mark E Peeples; Richard C Boucher; Peter L Collins; Raymond J Pickles
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

9.  Relative roles of pneumolysin and hydrogen peroxide from Streptococcus pneumoniae in inhibition of ependymal ciliary beat frequency.

Authors:  R A Hirst; K S Sikand; A Rutman; T J Mitchell; P W Andrew; C O'Callaghan
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

10.  Ciliary dyskinesia is an early feature of respiratory syncytial virus infection.

Authors:  Claire M Smith; Hemant Kulkarni; Priya Radhakrishnan; Andrew Rutman; Michael J Bankart; Gwyneth Williams; Robert A Hirst; Andrew J Easton; Peter W Andrew; Chris O'Callaghan
Journal:  Eur Respir J       Date:  2013-03-21       Impact factor: 16.671

View more
  43 in total

1.  Respiratory Syncytial Virus Bronchiolitis: Enter the Microbiome.

Authors:  James E Gern
Journal:  Am J Respir Crit Care Med       Date:  2016-11-01       Impact factor: 21.405

2.  Respiratory syncytial virus infection exacerbates pneumococcal pneumonia via Gas6/Axl-mediated macrophage polarization.

Authors:  Takehiko Shibata; Airi Makino; Ruiko Ogata; Shigeki Nakamura; Toshihiro Ito; Kisaburo Nagata; Yoshihiko Terauchi; Taku Oishi; Mikiya Fujieda; Yoshimasa Takahashi; Manabu Ato
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

3.  Direct interactions with influenza promote bacterial adherence during respiratory infections.

Authors:  Hannah M Rowe; Victoria A Meliopoulos; Amy Iverson; Perrine Bomme; Stacey Schultz-Cherry; Jason W Rosch
Journal:  Nat Microbiol       Date:  2019-05-20       Impact factor: 17.745

Review 4.  Close Encounters of the Viral Kind: Cross-Kingdom Synergies at the Host-Pathogen Interface.

Authors:  Hannah M Rowe; Jason W Rosch
Journal:  Bioessays       Date:  2019-11-06       Impact factor: 4.345

Review 5.  Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment.

Authors:  Cameron Griffiths; Steven J Drews; David J Marchant
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

6.  Airway Bacterial Colonization, Biofilms and Blooms, and Acute Respiratory Infection.

Authors:  Mollie G Wasserman; Robert J Graham; Jonathan M Mansbach
Journal:  Pediatr Crit Care Med       Date:  2022-06-29       Impact factor: 3.971

7.  Nasopharyngeal Microbiota, Host Transcriptome, and Disease Severity in Children with Respiratory Syncytial Virus Infection.

Authors:  Wouter A A de Steenhuijsen Piters; Santtu Heinonen; Raiza Hasrat; Eleonora Bunsow; Bennett Smith; Maria-Carmen Suarez-Arrabal; Damien Chaussabel; Daniel M Cohen; Elisabeth A M Sanders; Octavio Ramilo; Debby Bogaert; Asuncion Mejias
Journal:  Am J Respir Crit Care Med       Date:  2016-11-01       Impact factor: 21.405

Review 8.  Pneumococcal septic shock after neonatal respiratory syncytial virus bronchiolitis: A case report and literature review.

Authors:  Antonella Di Caprio; Elena Coccolini; Paola Zagni; Eleonora Vaccina; Laura Lucaccioni; Licia Lugli; Lorenzo Iughetti; Alberto Berardi
Journal:  Acta Biomed       Date:  2021-04-30

9.  Outcomes of respiratory viral-bacterial co-infection in adult hospitalized patients.

Authors:  Yingzhi Liu; Lowell Ling; Sunny H Wong; Maggie Ht Wang; J Ross Fitzgerald; Xuan Zou; Shisong Fang; Xiaodong Liu; Xiansong Wang; Wei Hu; Hung Chan; Yan Wang; Dan Huang; Qing Li; Wai T Wong; Gordon Choi; Huachun Zou; David Sc Hui; Jun Yu; Gary Tse; Tony Gin; William Kk Wu; Matthew Tv Chan; Lin Zhang
Journal:  EClinicalMedicine       Date:  2021-06-10

10.  Integrated omics endotyping of infants with respiratory syncytial virus bronchiolitis and risk of childhood asthma.

Authors:  Yoshihiko Raita; Marcos Pérez-Losada; Robert J Freishtat; Brennan Harmon; Jonathan M Mansbach; Pedro A Piedra; Zhaozhong Zhu; Carlos A Camargo; Kohei Hasegawa
Journal:  Nat Commun       Date:  2021-06-14       Impact factor: 17.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.